UNSPSC 51113203: Diaziquone

This classification denotes an ethylenimine compound with the molecular formula C16H20N4O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQL5EUP13W, chemically known as 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone but more generally known as diaziquone, which bears US NIH Compound Identifier 42616. European Medicines Agency schedules Diaziquone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07070MIG. The term DIAZIQUONE is an International Non-Proprietary Name.

UNSPSC 51113203 Diaziquone is a Commodity code covering procurement of this specific pharmaceutical intermediate or chemical reagent used in research, manufacturing, and laboratory applications. State and local governments procure diaziquone through this code primarily for public health laboratories, university research institutions, and medical facilities that conduct pharmaceutical development, quality assurance testing, or clinical research. The code serves a narrow technical market where buyers are typically state health departments, university systems, research institutes, and hospital networks rather than general-purpose municipal or county procurement offices.

The source provides no recent state or local contract opportunities tagged to UNSPSC 51113203, making current market activity under this code indeterminate. Without posted RFP, RFQ, IFB, or ITB records, geographic concentration, issuing-body patterns, and representative solicitation details cannot be characterized from available data. Firms considering pursuit should monitor state university purchasing systems, state laboratory procurement channels, and health-system cooperative vehicles for emerging demand, as diaziquone procurement is episodic and typically embedded in larger research or pharmaceutical-supply contracts rather than standalone solicitations.